{\rtf1\ansi\deff0
{\fonttbl
{\f1\fcharset2 Symbol;}{\f00\fcharset0 Arial;}
{\f10\fcharset0 Times New Roman;}
}
{\colortbl;\red0\green0\blue0;\red255\green255\blue255;\red0\green0\blue255;}
{\stylesheet{\f0;}
}
{\info{\upr{\author????????????}
{\*\ud\uc0{\author{\uc1\u77u\u97u\u114u\u99u\u111u\u115u\u32u\u68u\u243u\u115u\u101u\u97u}
}
}
}
{\upr{\keywords???????????????????????}
{\*\ud\uc0{\keywords{\uc1\u67u\u114u\u101u\u97u\u116u\u101u\u100u\u66u\u121u\u73u\u82u\u73u\u83u\u95u\u68u\u80u\u69u\u95u\u49u\u50u\u46u\u48u\u51u}
}
}
}
{\creatim\yr2014\mo09\dy07\hr22\min36}
}
\viewkind1\splytwnine\ftnlytwnine\htmautsp\nolnhtadjtbl\useltbaln\alntblind\lytcalctblwd\lyttblrtgr\lnbrkrule\nobrkwrptbl\snaptogridincell\allowfieldendsel\ApplyBrkRules\wrppunct\asianbrkrule\rsidroot6310308\newtblstyruls\nogrowautofit\paperh16840\paperw11907\margl595\margr2701\margb360\margt4998\cols2\colno1\colw998\colsr115\colno2\colw7497\colsr0\sb609\sl-1\par\pard\li0{\pict\picwgoal998\pichgoal1632\pngblip
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}
\par\column\pard\sl-1\fs2\par\pard\pard\lang1046\li192\ri1827\ql\fi0\sl-345\f00 \fs26\cbpat1{\fs26\charscalex91\b\i0\ul0\cf2\chcbpat1\f00 Risco de função \fs29\charscalex100\f10 hepática \fs26\charscalex91\f00 prejudicada (00178) \line\fs22\charscalex92 (2006, 2008, LOE 2.1) \par}
\pard
\pard\lang1046\ri5691\sb297\ql\fi0\sl-240\f00 \fs17\cbpat2{\fs17\charscalex100\b0\i\ul0\cf1\chcbpat2\f00 Domínio \fs19\i0\f10 2: \fs17\i\f00 Nutrição \line Classe \fs19\i0\f10 4: \fs17\i\f00 Metabolismo \par}
\pard
\pard\lang1046\li14\ri-1\ql\fi0\sl-360\f10 \fs20\cbpat2{\fs18\charscalex120\b\i0\ul0\cf1\chcbpat2\f00 Definição \fs20\charscalex100\b0\f10 Risco de disfunção hepática que pode comprometer a saúde. \par}
\pard
\pard\lang1046\li10\ri5625\sb278\ql\fi0\sl-230\f00 \fs20\cbpat2{\fs20\charscalex114\b\i0\ul0\cf1\chcbpat2\f00 Fatores de risco \par}
\pard
\sbknone\sect\pard\sectd\fs24\sl-163\par\pard\sbknone\sect\pard\cols2\colno1\colw4617\colsr417\colno2\colw3537\colsr0\pard\lang1046\li1411\ri9\ql\fi-278\sl-244\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Abuso de substâncias (p. ex., álcool, \line cocaína) \par\pard}
\pard
\pard\lang1046\li1411\ri9\ql\fi-278\sl-244\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Coinfecção por \fs19\charscalex115\b\i\f00 HN \par\pard}
\pard
\pard\lang1046\li1133\ri1636\sb393\ql\fi0\sl-230\f00 \fs20\cbpat2{\fs20\charscalex114\b\i0\ul0\cf1\chcbpat2\f00 Referências \par}
\pard
\column\pard\sl-1\fs2\par\pard\pard\lang1046\li278\ri8\sb4\ql\fi-278\sl-244\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Infecção viral (p. ex., hepatite A, \line hepatite B, hepatite C, Epstein-Barr) \par\pard}
\pard
\pard\lang1046\li278\ri8\ql\fi-278\sl-244\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Medicamentos hepatotóxicos (p. ex., \line paracetamol, estatinas) \par\pard}
\pard
\sbknone\sect\pard\sectd\fs24\sl-187\par\pard\sbknone\sect\pard\pard\lang1046\li1142\ri19\ql\fi0\sl-187\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 AASLD Practice Guideline (2004). \fs15\i Diagnosis, management, and treatment ofhepatitis \fs15\i0 C. Alexandria, VA: American \line Association for the Study of Liver Diseases. \par}
\pard
\pard\lang1046\li1142\ri19\ql\fi0\sl-187\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Fontana, R.J., \fs14\charscalex107\f00 & \fs15\charscalex100\f10 Lok, S.E (2002). Noninvasive monitoring of patients with chronic hepatitis C. \fs15\i Hepatology , 36(5 \line\fs15\i0 Suppl.), S57-S64. \par}
\pard
\pard\lang1046\li1142\ql\fi0\sl-244\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Hoofnagle, \fs14\f00 J. \fs15\f10 (2002). Course and outcome of hepatitis C. \fs15\i Hepatology, \fs15\i0 36(5 Suppl. 1): S21-S29. \par}
\pard
\pard\lang1046\li1142\ri19\ql\fi0\sl-187\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Laboratory Medicine Practice Guidelines (2000). \fs15\i Laboratory guidelines for screening, diagnosis and tnonitoring of \line hepatic injury. \fs15\i0 Washington, DC: National Academy of Clinical Biochemistry. \par}
\pard
\pard\lang1046\li1142\ri19\ql\fi0\sl-187\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 National Institute of Diabetes and Digestive and Kidney Diseases (2003). \fs15\i Chronic hepatitis C: Current disease \line management. \fs15\i0 Washington, DC: US Department of Health and Human Services. \par}
\pard
\pard\lang1046\li1142\ri19\ql\fi0\sl-187\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Palmer, M. (2000). \fs15\i Heptuitis Liver Disease: Whatyou need to know. \fs15\i0 Garden City Park, NY: Avery Publishing Group, \line\fs13\charscalex115\f00 pp, \fs15\charscalex100\f10 23, 26-31, 62-67, 72-73. \par}
\pard
\pard\lang1046\li1180\sb4488\ql\fi0\sl-288\f00 \fs14\cbpat2{\fs27\charscalex113\b\i0\ul0\cf1\chcbpat2\f10 236 \fs14\charscalex100\b0\f00 Domínio 2: Nutrição \par}
\pard
\sbknone\sect\pard\sectd}
